Pencil Biosciences
Synthetic gene-editing technology for therapeutic development and cell-line engineering
Highlights
- New on EvolcAdded 2026-11-07
About Pencil Biosciences
Pencil Biosciences develops a synthetic, modular gene-editing platform that is non-CRISPR and designed to edit without causing a DNA break or nick. The company targets therapeutic applications and cell-line engineering, including oncology and genetic diseases.
The company is based in Macclesfield, United Kingdom, and was founded in 2018. Its team includes scientists and specialists in gene editing and protein engineering; the company has reported completing a fundraise and receiving an Innovate UK Investor Partnership grant.
Product: A synthetic, modular gene-editing platform for therapeutic development and cell-line engineering.
Jobs at Pencil Biosciences
Leadership
- Rajik Ibrahim · Founder and AdvisorSource: company website
- Amanda Smith · CEOSource: company website
More biotech & pharma companies
Pentabind
AI-designed aptamers and molecular discovery services for biotech, diagnostics and therapeutics partnersYoung companyNew on EvolcPeptimatrix
Synthetic peptide hydrogels for 3D cell culture used by pharmaceutical, biotechnology and academic researchersYoung companyNew on EvolcPeptone
Drug discovery platform designing small-molecule candidates for hard-to-treat cancers and neurodegenerative disease targetsPetagene
Genomic data compression, cloud access and encryption software for genomics researchers and bioinformatics teamsNew on EvolcPfizer
Prescription medicines and vaccines for patients and healthcare professionals in the UKNew on EvolcPheno Therapeutics
Develops GPR17-targeting neuroprotective therapeutics for patients with multiple sclerosis and other neurological disordersNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Backend
- PHPHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerx-powered-by
- Response headerx-powered-by
- Response headerx-powered-by
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.